Amprion
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10355 Science Center Dr Ste 240, San Die...Phone Number
(858) 999-4413Website
www.amprionme.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Amprion
Amprion Diagnostics specializes in alpha-synuclein testing, offering the patented SAAmplify-α-SYN test for diagnosing cognitive and movement disorders such as Parkinson's disease, Lewy body dementia, and Alzheimer's. Their innovative approach provides biological clarity in diagnosis, significantly reducing the reliance on traditional symptom-based methods. The company serves patients, clinicians, and biopharmaceutical companies, aiming to enhance diagnostic accuracy and treatment efficacy. With a strong foundation in research and over 20,000 analyzed samples, Amprion is committed to advancing the understanding of neurodegenerative diseases.Explore more
Amprion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amprion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Amprion has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Amprion
Funding: Get notified immidiatlly once Amprion has new funding data
Earning: See what the market has to say on Amprion recently announced quarterly report
Amprion, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Amprion is spiking on competitors!
Click to see if Amprion had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Amprion launches new products
Recommended Actions
Find VP level buyers at Amprion
Find 2 more new buyers
Compare Similar Companies to Amprion
Compare insights from companies similar to Amprion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amprion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amprion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amprion.
Amprion Tech Stack
A closer look at the technologies used by Amprion
Amprion News & Media
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
SAN DIEGO--(BUSINESS WIRE)--Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic DiagnosticsFDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test
SAN DIEGO--(BUSINESS WIRE)--FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial TestAmprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
SAN DIEGO--(BUSINESS WIRE)--Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, is launching a new line of cerebrospinal fluid (CSF) biomarker panels: SAAmplify. Physicians and their patients will now have access to the most comprehensive set of biomarkers available to aid in the diagnosis of Parkinson’s disease, Lewy body dementia, and Alzheimer’s disease with the Lewy body variant. Each panel leverages Amprion’s flagship seed amplifiAmprion Exhibits at MDS International Congress of Parkinson’s Disease...
Amprion, a leader in diagnostics for neurodegenerative diseases, invites researchers and practitioners attending the MDS International Congress in Madrid to visit Amprion at booth #212 and discuss how... (PRWeb September 15, 2022) Read the full story at https://www.prweb.com/releases/amprion_exhibits_at_mds_international_congress_of_parkinsons_disease_and_movement_disorders_in_madrid_and_presents_scientific_insights_on_syntap_test_at_prion2022/prweb18901526.htm
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Amprion
Sign Up For FreeTo access detailed company insights
Amprion Diagnostics specializes in alpha-synuclein testing, offering the patented SAAmplify-α-SYN test for diagnosing cognitive and movement disorders such as Parkinson's disease, Lewy body dementia, and Alzheimer's. Their innovative approach provides biological clarity in diagnosis, significantly reducing the reliance on traditional symptom-based... Read More
